EA200200312A1 - Способы и композиции для ингибирования пролиферации клеток млекопитающих - Google Patents
Способы и композиции для ингибирования пролиферации клеток млекопитающихInfo
- Publication number
- EA200200312A1 EA200200312A1 EA200200312A EA200200312A EA200200312A1 EA 200200312 A1 EA200200312 A1 EA 200200312A1 EA 200200312 A EA200200312 A EA 200200312A EA 200200312 A EA200200312 A EA 200200312A EA 200200312 A1 EA200200312 A1 EA 200200312A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- methods
- mammalian cells
- inhibiting proliferation
- ribonuclease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
- C12Y301/27001—Ribonuclease T2 (3.1.27.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Описан способ предупреждения, ингибирования и/или обращения пролиферации, колонизации, дифференцировки и/или развития ненормально пролиферирующих клеток у субъекта. Этот способ выполняют введением этому субъекту терапевтически эффективного количества рибонуклеазы семейства Т2.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38541199A | 1999-08-30 | 1999-08-30 | |
PCT/IL2000/000514 WO2001015531A1 (en) | 1999-08-30 | 2000-08-29 | Methods of and compositions for inhibiting the proliferation of mammalian cells |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200200312A1 true EA200200312A1 (ru) | 2002-10-31 |
EA004929B1 EA004929B1 (ru) | 2004-10-28 |
Family
ID=23521271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200200312A EA004929B1 (ru) | 1999-08-30 | 2000-08-29 | Способы и композиции для ингибирования пролиферации клеток млекопитающих |
Country Status (15)
Country | Link |
---|---|
EP (3) | EP2294918B8 (ru) |
JP (2) | JP4808346B2 (ru) |
AT (1) | ATE421856T1 (ru) |
AU (1) | AU769011B2 (ru) |
CA (1) | CA2382303C (ru) |
CU (1) | CU23065A3 (ru) |
DE (1) | DE60041495D1 (ru) |
EA (1) | EA004929B1 (ru) |
ES (3) | ES2319096T3 (ru) |
HK (2) | HK1045081B (ru) |
IL (1) | IL148345A0 (ru) |
MX (1) | MXPA02002162A (ru) |
NZ (1) | NZ517579A (ru) |
WO (1) | WO2001015531A1 (ru) |
ZA (1) | ZA200201647B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL148345A0 (en) * | 1999-08-30 | 2002-09-12 | Yissum Res Dev Co | Methods of and compositions for inhibiting the proliferation of mammalian cells |
US7811981B2 (en) | 1999-08-30 | 2010-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods of and compositions for inhibiting the proliferation of mammalian cells |
CA2582041C (en) | 2004-09-29 | 2015-08-04 | Levava Roiz | Recombinant human t2 rnase and uses thereof |
CZ302164B6 (cs) * | 2008-06-20 | 2010-11-24 | Biologické centrum AV CR, v. v. i. | Rekombinantní rostlinná nukleáza jako protinádorové terapeutikum s nízkými nežádoucími úcinky |
WO2015114633A1 (en) | 2014-01-30 | 2015-08-06 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786457A (en) * | 1989-02-23 | 1998-07-28 | Colorado State University Research Foundation | Hormone-nuclease compounds and method for regulating hormone related diseases |
IL148345A0 (en) * | 1999-08-30 | 2002-09-12 | Yissum Res Dev Co | Methods of and compositions for inhibiting the proliferation of mammalian cells |
CA2582041C (en) * | 2004-09-29 | 2015-08-04 | Levava Roiz | Recombinant human t2 rnase and uses thereof |
-
2000
- 2000-08-29 IL IL14834500A patent/IL148345A0/xx unknown
- 2000-08-29 CA CA2382303A patent/CA2382303C/en not_active Expired - Fee Related
- 2000-08-29 ES ES00954879T patent/ES2319096T3/es not_active Expired - Lifetime
- 2000-08-29 NZ NZ517579A patent/NZ517579A/en not_active IP Right Cessation
- 2000-08-29 ES ES10183935T patent/ES2397052T3/es not_active Expired - Lifetime
- 2000-08-29 EP EP10183935A patent/EP2294918B8/en not_active Expired - Lifetime
- 2000-08-29 ES ES08168000T patent/ES2396998T3/es not_active Expired - Lifetime
- 2000-08-29 EP EP08168000A patent/EP2165605B1/en not_active Expired - Lifetime
- 2000-08-29 DE DE60041495T patent/DE60041495D1/de not_active Expired - Lifetime
- 2000-08-29 MX MXPA02002162A patent/MXPA02002162A/es active IP Right Grant
- 2000-08-29 CU CU20020044A patent/CU23065A3/es unknown
- 2000-08-29 WO PCT/IL2000/000514 patent/WO2001015531A1/en active Application Filing
- 2000-08-29 AU AU67228/00A patent/AU769011B2/en not_active Ceased
- 2000-08-29 JP JP2001519760A patent/JP4808346B2/ja not_active Expired - Fee Related
- 2000-08-29 AT AT00954879T patent/ATE421856T1/de not_active IP Right Cessation
- 2000-08-29 EP EP00954879A patent/EP1207755B1/en not_active Expired - Lifetime
- 2000-08-29 EA EA200200312A patent/EA004929B1/ru not_active IP Right Cessation
-
2002
- 2002-02-27 ZA ZA200201647A patent/ZA200201647B/en unknown
- 2002-09-05 HK HK02106527.7A patent/HK1045081B/zh not_active IP Right Cessation
-
2011
- 2011-07-06 JP JP2011149849A patent/JP5467076B2/ja not_active Expired - Fee Related
- 2011-07-22 HK HK11107656.7A patent/HK1157137A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1045081A1 (en) | 2002-11-15 |
ES2319096T3 (es) | 2009-05-04 |
EP2294918A1 (en) | 2011-03-16 |
EP1207755A4 (en) | 2004-11-10 |
CA2382303A1 (en) | 2001-03-08 |
EP2165605A1 (en) | 2010-03-24 |
AU769011B2 (en) | 2004-01-15 |
IL148345A0 (en) | 2002-09-12 |
EP1207755A1 (en) | 2002-05-29 |
EP2294918B1 (en) | 2012-10-10 |
JP5467076B2 (ja) | 2014-04-09 |
DE60041495D1 (de) | 2009-03-19 |
ES2397052T3 (es) | 2013-03-04 |
ZA200201647B (en) | 2003-05-28 |
CU23065A3 (es) | 2005-07-19 |
WO2001015531A1 (en) | 2001-03-08 |
ATE421856T1 (de) | 2009-02-15 |
EA004929B1 (ru) | 2004-10-28 |
EP2165605B1 (en) | 2012-10-10 |
HK1045081B (zh) | 2009-08-07 |
HK1157137A1 (en) | 2012-06-29 |
CA2382303C (en) | 2013-02-12 |
ES2396998T3 (es) | 2013-03-01 |
JP2011251971A (ja) | 2011-12-15 |
EP1207755B1 (en) | 2009-01-28 |
AU6722800A (en) | 2001-03-26 |
NZ517579A (en) | 2004-02-27 |
MXPA02002162A (es) | 2002-11-04 |
JP2003508411A (ja) | 2003-03-04 |
EP2294918B8 (en) | 2012-11-14 |
JP4808346B2 (ja) | 2011-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1091975T3 (da) | Ny cyclosporin med forbedret aktivitetsprofil | |
DE59902006D1 (de) | Wirkstoffhaltige aromatische copolyester | |
IT1295645B1 (it) | Apparecchio per l'elettroemanazione di principi attivi. | |
WO2003010291A3 (en) | Treatment of immune disorders and b cell disorders | |
ZA200202802B (en) | Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same. | |
WO2003048205A3 (fr) | Proteines a activite inhibitrice de l'il-6 | |
WO2001034641A8 (en) | Antimicrobial activity of the first cationic cluster of human lactoferrin | |
HK1157137A1 (en) | Use of a ribonuclease of the t2 family having actin-binding activity for inhibiting tumor angiogenesis | |
NO910874L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
DE60001266D1 (de) | Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung | |
ATE343391T1 (de) | Behandlung von pansenacidose mit amylasehemmern | |
ITMI950378A0 (it) | Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono | |
NO992504L (no) | Sammensetninger for behandling av jord, fremgangsmÕte for fremstilling derav, samt anvendelse | |
EA200000875A1 (ru) | Белки, взаимодействующие с каспазой-8 | |
WO2000001729A3 (en) | Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome | |
WO2002032445A3 (de) | Hemmung der interaktion zwischen oxidierte proteine und cd36 oder dessen wirkmechanismus | |
HUP0200679A2 (en) | Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients | |
NO992668D0 (no) | Topisk preparat for innf°ring av farmas°ytisk aktive peptidforbindelser i levende organismer | |
IT9048066A0 (it) | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono. | |
DE69709891D1 (de) | Chitosan enthaltende zusammensetzung | |
ITTO910697A1 (it) | Enzima immobilizzato, relativo procedimento di preparazione ed impiego | |
DE60112117D1 (de) | Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril | |
ZA200108398B (en) | Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein. | |
ES2182340T3 (es) | Oligonucleotidos quimericos y su uso. | |
ITRM920520A1 (it) | Granuli liofilizzati contenenti microorganismi fungini, e procedimento per la loro preparazione. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |